Detalhe da pesquisa
1.
Rituximab or cyclosporine a for the treatment of membranous nephropathy: Economic evaluation of the MENTOR trial.
Nephrol Dial Transplant
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621719
2.
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification.
Kidney Int
; 104(6): 1092-1102, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795587
3.
An update on corticosteroid treatment for IgA nephropathy.
Curr Opin Nephrol Hypertens
; 32(3): 263-270, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36866805
4.
Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study.
Am J Kidney Dis
; 82(6): 725-736, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516296
5.
A Population-Based Analysis of the Risk of Glomerular Disease Relapse after COVID-19 Vaccination.
J Am Soc Nephrol
; 33(12): 2247-2257, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332971
6.
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy.
Kidney Int
; 102(1): 160-172, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35490842
7.
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
N Engl J Med
; 381(1): 36-46, 2019 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31269364
8.
The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.
Am J Kidney Dis
; 80(6): 740-750, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659570
9.
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.
Diabetes Obes Metab
; 24(8): 1578-1587, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35478433
10.
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.
J Am Soc Nephrol
; 32(2): 436-447, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33514642
11.
Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression.
Kidney Int
; 99(5): 1127-1139, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417998
12.
Updating the International IgA Nephropathy Prediction Tool for use in children.
Kidney Int
; 99(6): 1439-1450, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33220356
13.
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease.
Kidney Int
; 100(4): 881-893, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33964313
14.
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool.
Kidney Int
; 98(4): 1009-1019, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32464215
15.
How to optimize the design and implementation of risk prediction tools: focus group with patients with IgA nephropathy.
BMC Med Inform Decis Mak
; 20(1): 231, 2020 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32938443
16.
Disease-specific incident glomerulonephritis displays geographic clustering in under-serviced rural areas of British Columbia, Canada.
Kidney Int
; 96(2): 421-428, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31113679
17.
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney Int
; 95(2): 268-280, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665568
18.
PROTECTing the kidneys in IgA nephropathy.
Lancet
; 402(10417): 2046-2047, 2023 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931627
19.
Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study.
BMC Nephrol
; 18(1): 95, 2017 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28320366
20.
The MEST score provides earlier risk prediction in lgA nephropathy.
Kidney Int
; 89(1): 167-75, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26759049